Good to adequate presurgical Karnofsky performance scores (KPS ≥ 70) showed a trend toward improved OS (mean OS: 109 vs. 68.2 months; p < 0.1), while patients with preradiotherapy KPS ≥ 70 had significantly better OS (median OS: 39.8 months vs. not applicable (NA); p < 0.01).
The association between TP53 mutation and CDKN2A deletion showed a trend towards mutually exclusivity (Fisher’s exact test, P = 0.10).
IVT showed a trend toward being less performed in the EVT group (21.7 vs. 41.1%, p = 0.1), while other baseline parameters were balanced.
At day 0.5, the expression of Opn1sw showed a trend to decrease after MNU-S treatment ( p = 0.10) while no difference from control was observed after MNU-T and MMS treatment (Fig. 3 A).
Regarding fecal acetic acid ( Figure 4 a), as the trial progressed, the LBP group showed a trend toward increased acetic acid levels ( p < 0.1); and the LbGP group showed an increase in acetic acid levels ( p < 0.01).
Consistent with a more effective bacterial elimination in cerebellum, animals pre-treated with PEA showed a trend toward lower chemokine levels compared to controls ( P = 0.10, multivariate rank-sum test followed by Holm–Bonferroni correction, Figure 4D ).
This was not the case with the American sample, which showed a trend in the correlation for the HTKS efficiency measure ( p < 0.1) although the magnitude of the correlation was similar to that of the Brazilian sample.
Type 1 showed a trend toward a higher frequency in the NF group (adjusted residual = 1.897, 0.05 ≤ p < 0.10).
However, we did not find strong evidence that major discrimination experience amplified age-related decline in neurite density (the association showed a trend, P <.1).
Linear regression analysis showed a trend between the TIRM SI and the difference in T1 SI (p<0.1, R 2 = 0.1).
Several previously documented risk factors showed a trend for an association with VOD rate in the younger cohort including a hematopoietic cell transplantation–specific comorbidity index score of >3 (23% vs 12%; P = .1), myeloablative TBI compared with no myeloablative TBI (26% vs 15%; P = .2), and patients with ALL and exposure to InO compared with those with ALL not receiving InO (33 vs 21, P = .1).
Predictors that showed a trend ( P <0.1) that differed in the univariate test were included in the multivariable logistic regression.
76 Furthermore, patients taking atovaquone showed a trend towards lower zidovudine/glucuronide plasma concentrations (6% reduction in AUC 0-8 , P < 0.1) and a significant decrease in the ratio between zidovudine/glucuronide and plasma concentrations (30% reduction, P < 0.05).
coagulans GBI-30, 6086 showed a trend ( p = 0.10) to increase vertical jump power in comparison to casein alone, and might had a beneficial effect on peak power and fat mass (Fig. 1 ).
analyzed 61 neoadjuvant treated GC patients and found that the high expression of ERCC4 mRNA showed a trend for a correlation with shortened survival (P=0.10) [ 44 ].
When compared to the placebo group at week 20, reduced triglyceride levels in the PTE group showed a trend ( P <0.1) ( Figure 4D ).
However, twenty additional metabolites showed a trend towards differential abundance at a relaxed stringency ( p -value < 0.1), with most showing fold changes smaller but in the same direction as in Maf1 −/− mice, pointing to effects on the same pathways.
However, the subspecies distribution showed a trend for higher C18, C20, C22, C24:1 and C24 in the aged fractions ( p <0.1) ( Fig.
MC4R rs12970134 SNP did not show any significant association, but minor allele “A” of MC4R showed a trend towards association with FPI, diastolic BP and triglyceride levels ( p < 0.1).
Overall median survival difference The overall median survival difference for cancer patients treated with psychosocial interventions showed a trend with a survival benefit of 3.9 months, 95% CI [−0.7, 8.5], SE = 2.34, z = 1.66, p = 0.10; based on articles that provided sufficient data ( k = 16).
CD244 [2B4], another NK activating receptor, showed a trend towards up-regulation by UMCD6 ( p < 0.1).
Variables that reached statistical significance ( p ≤ 0.05) and those that showed a trend towards association with knowledge score ( p ≤ 0.1 was accepted), were included in the multivariate model.
Although the overall model was not statistically significant (LR χ 2 (4) = 6.11, p = 0.191), anemia showed a trend toward lower odds of undernutrition (OR = 0.15, 95% CI: 0.02–1.44, p = 0.100), and increasing age group was associated with a slight increase in odds (OR = 1.80, 95% CI: 0.88–3.68, p = 0.109).
In addition, Mag mRNA expression showed a trend for a negative correlation with OFC ( r (11) =−0.555, P <0.1).
Compared with AD group, SIVD group showed a trend of higher scores of agitation in hyperactivity domain in the very-mild dementia stage (p<0.10) and significantly higher scores of apathy domain in the mild-to-moderate dementia stage (p<0.01).